GlassScriptPhysician profile
Christopher M Perez
NPI 1538134226
$8,914.32
in general payments reported to CMS, 2019-2025
44 companies · $1,888 in 2025
The $1,888 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,423 · 2020: $1,065 · 2021: $1,243 · 2022: $997 · 2023: $1,066 · 2024: $1,232 · 2025: $1,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,186.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,199.74 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $1,119.32 | 2019-2025 | Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $994.40 | 2019-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $938.84 | 2019-2025 | Ztlido |
| Braeburn INC. | $515.12 | 2024-2025 | Brixadi |
| Pfizer INC. | $489.19 | 2019-2025 | |
| Forte Bio-Pharma LLC | $477.19 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Indivior INC. | $456.20 | 2019-2025 | Sublocade |
| Lundbeck LLC | $299.36 | 2021-2025 | Vyepti |
| Daiichi Sankyo INC. | $264.79 | 2019 | |
| Biodelivery Sciences International, INC. | $264.43 | 2019-2021 | |
| Hikma Pharmaceuticals USA | $167.36 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $166.42 | 2019-2024 | Ajovy |
| Biohaven Pharmaceuticals, INC. | $140.98 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $132.95 | 2022-2023 | Quviviq |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.